Detalhe da pesquisa
1.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 78(2): 259-268, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740559
2.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis
; 76(3): e1157-e1165, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031403
3.
Characteristics of community-acquired carbapenem-resistant Enterobacterales.
J Antimicrob Chemother
; 77(10): 2763-2771, 2022 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179278
4.
The Data and Safety Monitoring Board: The Toughest Job in Clinical Trials.
NEJM Evid
; 2(2): EVIDctw2200220, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320039
5.
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection.
Open Forum Infect Dis
; 9(6): ofac140, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615299